Company intelligence / Profile preview

Microspherix

Boca Raton, Florida, United States

Ownership: Private
Development stage: Other

Overview

Microspherix is a privately held biotechnology company specializing in implantable, image-guided drug- and radiation-delivery devices for oncology, particularly brachytherapy and "entotherapy" methods. Its core innovation is a patented seed for permanent brachytherapy that improves MRI imaging and prevents migration, addressing major weaknesses of conventional therapies. The company is piloting its entotherapy product in collaboration with veterinary colleges and has been involved in high-profile patent litigation with Merck and Organon over drug-eluting seed implant technology.

Therapeutic areas: Oncology
Modalities: DeviceDrug-eluting implantRadiopharmaceutical
Industry: Implantable Medical Devices

Partnerships

BioSurfaces, Inc.NuVascular Technologies

Beyond the preview

Go deeper on Microspherix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microspherix.

Explore the full profile